Salonpas

From Self-sufficiency
Revision as of 01:35, 16 September 2010 by Yobot (Talk) (Removing obsolote parameters from template + genfixes using AWB (7131))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Salonpas is a brand name of a line of over-the-counter (OTC) pain relieving products manufactured by Hisamitsu Pharmaceutical Co., Inc. of Tosu City, Japan. Introduced to the Japanese market in 1934, Salonpas is now sold in approximately fifty countries.[1] The largest markets for the products are Japan and other Asian nations such as Vietnam, Philippines, Malaysia, Taiwan and other nations. According to Hisamitsu, approximately 20 billion Salonpas transdermal patches have been sold in last 20 years.[2]

Similar products are marketed by other companies, including Absorbine Jr. Pain Relief, Excedrin Cooling Pads, and Icy Hot Patches.[3] Unlike patches containing fentanyl, topical analgesics containing menthol, methyl salicylate, camphor, and capsaicin and are available without a prescription.[4]

In 2008, Salonpas Pain Relief Patch and Salonpas Arthritis Pain products were approved as the first (and sole) OTC topical analgesic patch by the U.S. Food and Drug Administration (FDA).[4]

Products

Summary of Salonpas brand products sold in the U.S.

· Salonpas Pain Relief Patch - FDA approved OTC pain relief patch. Active ingredients: Methyl Salicylate 10%, Menthol 3%

· Salonpas Arthritis Pain - FDA approved OTC pain relief patch. Active ingredients: Methyl Salicylate 10%, Menthol 3%

· Salonpas - Versatile sized OTC pain relief patch. Active ingredients: Methyl Salicylate 6.3%, Menthol 5.7%, Camphor 1.2%

· Salonpas Hot - Large size capsaicin patch for application for back—OTC pain relief patch. Active ingredient: Capsicum extract 0.025% as Capsaicin

· Air Salonpas - OTC pain relief aerosol spray. Active ingredients: Methyl Salicylate, 1.75% Menthol 3.2%, Camphor 3.0%

· Salonpas Gel - Menthol and Methyl Salicylate gel—OTC pain relief gel. Active ingredients: Methyl Salicylate 15%, Menthol 7%)

· Salongsip Aqua-Patch - Menthol jelly patch—Jelly type OTC pain relief patch. Active ingredient: Menthol 1.25%

· Salonpas Gel-Patch - Menthol and capsaicin jelly patch—Active ingredients: Capsicum extracts]0.025% as Capsicum, Menthol 1.25%

FDA approval

In February 2008, the FDA approved a New Drug Application (NDA) covering Salonpas Pain Relief Patch and Salonpas Arithitis Pain, topical pain-relieving patches. These patches contain recognized analgesic ingredients (Menthol, Methyl Salicylate) called counterirritants that when applied to the skin diminish pain signals under areas to which they are administered. To date, the Salonpas Pain Relief Patch and Salonpas Arthritis Pain patch are the only external analgesic patches subject to an approved NDA and sold into the over-the-counter health care market.[5]

The effectiveness of the Salonpas Pain Relief Patch and Salonpas Arthritis Pain patch have been established in a clinical trial. The Salonpas patch was found to provide significantly greater pain relief compared to a placebo patch.[6][non-primary source needed] The Salonpas Pain Relief Patch and Salonpas Arthritis Pain patches are manufactured using what Hisamitsu calls “comfort stretch” technology that provides effective pain relief while allowing patients to maintain daily activities and, an alternative for those who prefer to avoid the use of oral OTC pain relief medication for minor aches and pains. The company differentiates its products from oral medications because the active ingredients in Salonpas patches are absorbed through the skin and go directly to the site of the pain.[citation needed]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

External links

  • "History". Hisamitsu. Hisamitsu Pharmaceutical Co. 2010. Retrieved 2010-08-16. 
  • Hisamitsu Pharmaceutical Co., Inc. Company Guide
  • Levy, Sandra (10 December 2001). "External painkillers lead sales in analgesics market". Drug Topics. Retrieved 2010-03-05. 
  • 4.0 4.1 Pray, W. Steven (1 September 2008). "The pharmacist's role in the appropriate selection of a nonprescription product for pain relief". U.S. Pharmacist. Retrieved 2010-03-05. 
  • http://www.otcproductnews.com/otc-product-news/hisamitsu-charts-the-future-of-topical-patches.html[dead link]
  • "White Paper – Clinical Trials". Salonpas®. Hisamitsu America, Inc. 2010. Retrieved 2010-08-16.